Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy | MicrobiomeTrials← Back to trialsNCT07637942
Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07-15Est. Completion: 2028-02-15
Enrollment target: 40 participants Locations- Site 4601, University of California, UC San Diego CRS, La Jolla, California, United States
- Site 5048, University of Southern California, Los Angeles, California, United States
- Site 5052, University of Colorado, Aurora, Colorado, United States
- Site 5030, Emory University School of Medicine, Atlanta, Georgia, United States
- Site 4001, Lurie Children's Hospital of Chicago CRS, Chicago, Illinois, United States
- Site 5092, Johns Hopkins University, Baltimore, Maryland, United States
- Site 5013, Jacobi Medical Center Bronx, The Bronx, New York, United States
- Site 6201, University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Site 6501, St Jude Children's Research Hospital, Memphis, Tennessee, United States
- Site 5128, Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, United States
Other microbiome trials you might be interested in
HIV InfectionsAdherence, Medication
The investigators will implement a 24-month fractional factorial design study (Aim 1). The investigators will recruit 51…
Cape Town, South AfricaEst. completion May 28, 2026
HIV-1-infection
The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with hum…
Buenos Aires, ArgentinaEst. completion Mar 2034
Lisa Levy
Recruiting
Substance Use DisordersHIV Infections
This is a multi-phased study, funded through a National Institute on Drug Abuse (NIDA) K24 grant that aims to ultimately…
Charleston, United StatesEst. completion Aug 31, 2026